Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion type Assertion NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_head.
- NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion description "[This study reviews the advances in molecular understanding of IBC and focuses on the efficacy of therapies that target the epidermal growth factor pathway and angiogenesis as well as early investigational therapies involving RhoC and TP53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_provenance.
- NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion evidence source_evidence_literature NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_provenance.
- NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion SIO_000772 20133255 NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_provenance.
- NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion wasDerivedFrom befree-20140225 NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_provenance.
- NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_assertion wasGeneratedBy ECO_0000203 NP508308.RAAnV1rIc_i8BqlM8Ag0tmN58dI29dbv99-9rNeCY2o5Q130_provenance.